America Great Health (AAGH)
OTCMKTS · Delayed Price · Currency is USD
0.0005
-0.0001 (-16.67%)
Jun 5, 2025, 3:56 PM EDT
-80.77%
Market Cap 6.35M
Revenue (ttm) 382.86K
Net Income (ttm) -1.09M
Shares Out 21.15B
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 44,803,299
Average Volume 9,889,378
Open 0.0006
Previous Close 0.0006
Day's Range 0.0005 - 0.0006
52-Week Range 0.0001 - 0.0180
Beta 5.12
RSI 34.06
Earnings Date Jun 2, 2025

About America Great Health

America Great Health operates as a biotechnology company in the United States. It focuses on the research and development of protein and peptide small molecular drugs; and manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy, and regenerative medicine and nutritional dietary supplements. The company was formerly known as Crown Marketing and changed its name to America Great Health in March 2017. America Great Health is based in Alhambra, California. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Mike Wang
Employees 5
Stock Exchange OTCMKTS
Ticker Symbol AAGH
Full Company Profile

Financial Performance

In 2024, America Great Health's revenue was $294,670, an increase of 44.23% compared to the previous year's $204,308. Losses were -$1.22 million, 60.3% more than in 2023.

Financial Statements

News

There is no news available yet.